Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular
Status:
Completed
Trial end date:
2018-05-04
Target enrollment:
Participant gender:
Summary
This is a Multi-center, Randomized, Double-blinded, Placebo-controlled, Parallel-design,
12-Week, Therapeutic exploratory, Phase IIa Study which will patients with type 2 diabetes
mellitus and recent cardiovascular complications.